4-methyl-2,6-diisobornylphenol

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2016
01220092016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Excretion of highly lipophilic (log P = 8.14) 4-methyl-2,6-diisobornylphenol (IBP) from rats was evaluated from renal excretion… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2016
2016
We compared bioavailability of 4-methyl-2,6-diisobornylphenol after single intragastric administration to rats in a dose of 200… (More)
  • figure 1
  • table 1
Is this relevant?
2014
2014
We have studied the distribution of the new compound 4-methyl-2,6-diisobornylphenol in rats after a single oral administration in… (More)
Is this relevant?
2014
2014
The linearity of pharmacokinetics of 4-methyl-2,6-diisobornylphenol after single intragastric administration in doses within 10… (More)
Is this relevant?
2011
2011
The pharmacokinetics of 4-methyl-2,6-diisobornylphenol (MDIBP) in rat blood plasma has been studied after intravenous injection… (More)
Is this relevant?
2011
2011
Methods for monitoring the quality of the new pharmaceutical substance 4-methyl-2,6-diisobornylphenol (dibornol) were developed. 
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2010
2010
Along with microangiopathy, one of the main causes of blindness in diabetic retinopathy consists of degeneration of retinal… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2009
2009
Along with microangiopathy, degeneration of retinal neurons is one of the basic causes of blindness in patients with diabetic… (More)
Is this relevant?
2009
2009
Neuroprotective activity of the new sterically hindered phenolic antioxidant 4-methyl-2,6-diisobornylphenol (dibornol) in rats… (More)
Is this relevant?